Janssen turns to Danish startup for pill to replace the need to inject drugs
![Biograil CEO Karsten Lindhardt and CTO Nikolaj Skak. | Photo: Biograil / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12594398.ece/ALTERNATES/schema-16_9/doc7df9u00k6me1idgz41d1.jpg)
In the beginning of 2020, when MedWatch interviewed the people behind the young biotech firm Biograil, they indicated that they were looking for partners within the pharmaceutical industry. Now – just under a year later – they managed to poach the first one.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.